apo-bromocriptine
apotex nz ltd - bromocriptine mesilate 2.9mg equivalent to bromocriptine 2.5 mg (2.9 - 3.0 mg) - tablet - 2.5 mg - active: bromocriptine mesilate 2.9mg equivalent to bromocriptine 2.5 mg (2.9 - 3.0 mg) excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - prolactin dependent menstrual cycle disorders (amenorrhoea, oligomenorrhoea, galactorrhoea), and/or female infertility associated with hyperprolactinaemia or luteal phase deficiency: · bromocriptine may normalise the menstrual cycle and/or induce ovulation without ovarian overstimulation. treatment with bromocriptine is not curative and it is not effective in treating ovarian failure.
cryomarex rispens
merial animal health limited - marek disease virus (rispens strain) - suspension for injection - unknown - avian herpes virus vaccine (mareks disease) - fowl - chicken - immunological - live vaccine
cryomarex rispens
boehringer ingelheim animal health uk ltd - marek's disease virus - suspension for injection - live viral vaccine - chickens
cryomarex rispens
merial animal health limited - marek disease virus (rispens strain) - suspension for injection - . - avian herpes virus (marek's disease) - chickens - immunological - live vaccine
natural-knee® ii system revision posterior stabilizing bar size 00-4 - uncoated knee tibia prosthesis, metallic
zimmer biomet pty ltd -
parlodel tab 2.5mg tablet
novartis pharmaceuticals canada inc - bromocriptine (bromocriptine mesylate) - tablet - 2.5mg - bromocriptine (bromocriptine mesylate) 2.5mg - ergot-derivative dopamine receptor agonists
bromocriptine tablet
aa pharma inc - bromocriptine (bromocriptine mesylate) - tablet - 2.5mg - bromocriptine (bromocriptine mesylate) 2.5mg - ergot-derivative dopamine receptor agonists
bromocriptine capsule
aa pharma inc - bromocriptine (bromocriptine mesylate) - capsule - 5mg - bromocriptine (bromocriptine mesylate) 5mg - ergot-derivative dopamine receptor agonists
anipryl- selegiline hydrochloride tablet
zoetis inc. - selegiline hydrochloride (unii: 6w731x367q) (selegiline - unii:2k1v7gp655) - selegiline hydrochloride 2 mg - anipryl tablets are indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (cds) and control of clinical signs associated with uncomplicated canine pituitary dependent hyperadrenocorticism (pdh). anipryl is contraindicated in patients with known hypersensitivity to this drug. in humans, selegiline is contraindicated for use with meperidine and this contraindication is often extended to other opioids.
rebinyn powder for solution
novo nordisk canada inc - coagulation factor ix (recombinant), pegylated - powder for solution - 500unit - coagulation factor ix (recombinant), pegylated 500unit - hemostatics